Skip to main content

Table 3 Association between MEST-C score and baseline eGFR in STOP-IgAN patients

From: Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)

  Mean eGFRa,b p-value
Mesangial hypercellularity   0.674
 M0 62 ± 26  
 M1 65 ± 34  
Endocapillary hypercellularity   0.308
 E0 64 ± 27  
 E1 53 ± 34  
Segmental glomerulosclerosis   0.422
 S0 74 ± 34  
 S1 61 ± 27  
Tubular atrophy/Interstitial fibrosis   < 0.0001
 T0 75 ± 28  
 T1/2 45 ± 16  
Crescents   0.815
 C0 62 ± 29  
 C1/2 64 ± 25  
  1. aend of the 6-month run-in phase
  2. b ml/min/1.73m2